| 2021 | | Efficacy and safety of DWJ1252 compared with gasmotin in the treatment of functional dyspepsia: A multicenter, randomized, double-blind, active-controlled study | 이광재 |
| 2006 | | Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial. | 이은현, 함기백 |
| 2013 | | Efficacy and safety of entecavir plus carnitine complex (GODEXⓇ) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study | 정재연, 조성원 |
| 2017 | | Efficacy and Safety of Ethanol Ablation for Branchial Cleft Cysts | 김철호, 하은주, 한미란 |
| 2023 | | Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension | 김혜진 |
| 2018 | | Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia | 황교승 |
| 2023 | | Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis | 이광재 |
| 2016 | | Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong) | 박진선, 신준한 |
| 1999 | | Efficacy and Safety of Glimepiride: A Novel Sulfonylurea Drug Compared with Gliclazide in the Treatment of Type 2 Diabetes Mellitus: an Open, Randomized Comparative Multi-Center Clinical Study | 이관우 |
| 2022 | | Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trials | 이은소 |
| 2023 | | Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study | 이광재 |
| 2012 | | Efficacy and safety of human placental extract solution on fatigue: a double-blind, randomized, placebo-controlled study | 박샛별 |
| 2023 | | Efficacy and Safety of Infliximab in Intestinal Behçet's Disease: A Multicenter, Phase 3 Study (BEGIN) | 신성재 |
| 2016 | | Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study | 신성재 |
| 2017 | | Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study) | 이관우 |
| 2024 | | Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia | 서창희 |
| 2021 | | Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke | 이진수 |
| 2018 | | Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial | 이관우 |
| 2013 | | Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency. | 이해상, 황진순 |
| 2024 | | Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials | 예영민 |
